Rajeev Ayyagari




Ph.D., biostatistics, Harvard University; M.S., computer science, University of Maryland; M.A. and B.A., statistics, Indian Statistical Institute

Summary of Experience

Dr. Ayyagari is experienced in the application of outcomes research and statistical techniques to the study of clinical and economic outcomes in a broad range of disease areas, including diabetes, cardiovascular disease, oncology, psychiatry, immunology, and infectious diseases. His expertise includes comparative efficacy and safety, cost-effectiveness, risk prediction, missing data problems, identification of causal effects in observational studies, robust estimation, and indirect and mixed treatment comparisons. His recent work includes evaluating the comparative efficacy of interventions in diabetes, ADHD, and oncology for regulatory submissions, assessing the causal effect of adherence on diabetes outcomes, developing stroke risk models incorporating pulse pressure, supporting an expert witness on a major drug safety litigation, and leading the development of software tools to communicate the economic value of therapies. Prior to joining Analysis Group, Dr. Ayyagari was a research fellow at the Harvard School of Public Health, and a biostatistician with Information Management Services Inc. His research has been published in the Journal of the American Statistical Association, the Journal of the National Cancer Institute, Cancer Treatment Reviews, Pediatric Pulmonology, and elsewhere. He has presented his work at health care and data mining conferences.

Selected Publishing